ImmuPharma plc (LON:IMM – Get Free Report)’s stock price rose 191.7% during trading on Thursday . The company traded as high as GBX 3.80 ($0.05) and last traded at GBX 3.50 ($0.04). Approximately 104,299,430 shares changed hands during mid-day trading, an increase of 470% from the average daily volume of 18,292,627 shares. The stock had previously closed at GBX 1.20 ($0.01).
ImmuPharma Price Performance
The firm’s 50 day simple moving average is GBX 1.40 and its two-hundred day simple moving average is GBX 1.65. The firm has a market capitalization of £15.30 million, a P/E ratio of -367.30 and a beta of 1.53.
About ImmuPharma
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Featured Stories
- Five stocks we like better than ImmuPharma
- Earnings Per Share Calculator: How to Calculate EPS
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What Are Some of the Best Large-Cap Stocks to Buy?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Market Cap Calculator: How to Calculate Market Cap
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
